New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
07:56 EDTPFE, BAC, DTV, JPM, AZN, T, LAZLazard shares rise after AT&T mega-deal struck, WSJ says
Shares of Lazard (LAZ) rose yesterday after AT&T (T), which Lazard was the advisor for, announced its deal to acquire DirecTV (DTV), reported The Wall Street Journal. In contrast, JPMorgan (JPM), Bank of America (BAC) and Guggenheim Partners look set to be disappointed and lose out on potential fees as Pfizer's (PFE) bid for AstraZeneca (AZN) appears destined to fail, the report noted. The Journal added that the total value of agreed-upon U.S. deals is up 87% from last year to $585B year-to-date. Reference Link
News For LAZ;JPM;BAC;T;DTV;PFE;AZN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
December 5, 2014
10:35 EDTJPMJPMorgan hits fresh 52-week high, levels to watch
Subscribe for More Information
10:22 EDTPFEBristol-Myers call activity attributed to takeover speculation
Subscribe for More Information
10:10 EDTJPMJPMorgan CEO Jamie Dimon seeing no evidence of cancer after treatment, CNBC says
Subscribe for More Information
10:05 EDTPFEBristol-Myers jumps 2% amid talk of potential Pfizer bid
Shares of Bristol-Myers (BMY) are up in early trading amid chatter of a potential takeover bid from Pfizer (PFE). The stock is up $1.26 to $60.15. Bristol's market capitalization stands around $99B, less than twice that of Pfizer's $200B. A Jefferies analyst last week called Mylan (MYL) the most likely takeover target for Pfizer. Pfizer is "highly motivated" to buy a foreign company using its overseas cash and Mylan looks like the most likely target, Jefferies analyst Jeffrey Holford wrote.
09:56 EDTPFERumor: Bristol-Myers strength attributed to takeover speculation
Subscribe for More Information
09:49 EDTAZNUBS European pharmaceuticals analysts holds analyst/industry conference call
Subscribe for More Information
09:36 EDTBACActive equity options trading
Subscribe for More Information
06:01 EDTT, DTVTechNet: Combined AT&T/DirecTV will increase broadband development
Subscribe for More Information
December 4, 2014
08:45 EDTAZN, PFEAbbVie price target raised to $80 from $72 at Jefferies
Jefferies raised its price target for AbbVie shares to $80 while calling the company one of its top five global pharma picks for 2015. The firm's top U.S. pick is Pfizer (PFE) and its top Europe pick is Novartis (NVS). Bayer (BAYRY) and AstraZeneca (AZN) round out the top five. Jefferies thinks AbbVie's "strong momentum" will continue into the first half of 2015 and keeps a Buy rating on the name.
07:16 EDTBACConsumer Federation of America to hold a conference
Subscribe for More Information
06:10 EDTDTVDirecTV contract with HBO has clauses for streaming, WSJ reports
DirecTV's (DTV) contract with Time Warner's (TWX) HBO has clauses should the premium channel's streaming-video service sign up more than 450,000 subscribers nationally, Wall Street Journal reports, citing people familiar with the matter. If the subscriber number is hit, DirecTV could scale back its marketing of HBO and get the right to offer the streaming product, the Journal adds. Reference Link
06:02 EDTBACStocks with implied volatility movement; BAC AMZN
Subscribe for More Information
December 3, 2014
19:11 EDTAZNAstraZeneca, Shire interested in Ariad, Daily Mail reports
Ariad (ARIA) is trading higher on speculation that both AstraZeneca (AZN) and Shire (SHPG) are interested in the company with the possibility of an ensuing auction, according to the Daily Mail, which added that analysts see an acquisition price for Ariad of more than $20 per share. Reference Link
17:12 EDTPFEPfizer reports positive results from PROFILE 1014 study
Subscribe for More Information
16:42 EDTPFEDiplomat chosen as limited-distribution pharmacy partner by Pfizer
Subscribe for More Information
10:50 EDTDTV, TFCC restarts clock on Time Warner Cable/Comcast and AT&T/DirecTV deals
Subscribe for More Information
10:41 EDTJPMPresident Obama to speak to members of the Business Roundtable
President Obama speaks to members of the Business Roundtable, including CEO Dimon of JPMorgan, CEO Spiegel of Siemens, CEO Tillerson of Exxon Mobil and CEO Wilderotter of Frontier Communications on December 3 at 11:15 am. Webcast Link
08:10 EDTTDISH downgraded to Sell with $67 target at Wunderlich
Wunderlich downgraded DISH (DISH) to Sell from Hold saying it sees only a 30% chance of all the company's spectrum getting monetized in 2015. Further, Wunderlich believes spectrum owned by Verizon (VZ) and AT&T (T) is worth more than DISH's spectrum, making auction valuation extrapolations "tricky." The firm raised its price target for DISH shares to $67 from $60.
07:20 EDTJPMThe Economist to hold a summit
Subscribe for More Information
07:16 EDTPFEFood & Drug Law Institute to hold a conference
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use